Viewing Study NCT00171795


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-01-04 @ 4:38 PM
Study NCT ID: NCT00171795
Status: COMPLETED
Last Update Posted: 2011-11-23
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module